Recent medical guidelines call for changing how women's heart health is monitored by continuously assessing risk factors from puberty through menopause and beyond, rather than treating health issues at each stage as separate conditions.
These recommendations came within a joint medical framework prepared by four major health organizations: the American Heart Association, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine. This is the first joint coordinating framework between these entities focusing on the prevention, detection, and management of cardiovascular disease in girls and women.
These recommendations are particularly important given that cardiovascular disease, including heart attacks and strokes, is the leading cause of death among women in the United States, causing over 400,000 deaths annually, according to the American Heart Association.
Four Stages in a Woman's Life Reveal Heart Health Indicators
The guiding framework divides a woman's life into four main stages that can help assess risks associated with heart health:
The pre-menarche stage and around the first menstruation, with the onset of puberty.
The stage of regular menstrual cycles and regular ovulation.
The premenopause stage.
The postmenopause stage.
Dr. Molly Siegel, Medical Director of Obstetrics and Gynecology at Mass General Health centers, explains that the core message of the recommendations is the need to monitor heart disease risks throughout a woman's life, rather than dealing with each health issue in isolation.
The indicators recommended for monitoring include menstrual cycle patterns, hormonal and endocrine disorders, pregnancy complications, and mental health, as these factors may provide important information about the future probability of developing cardiovascular disease.
Pregnancy Complications May Reveal Future Heart Disease Risks
The recommendations highlight the importance of pregnancy in assessing heart health, describing it as a natural stress test for the cardiovascular system that can reveal health issues whose effects may appear later.
The most notable complications that may be linked to a higher risk of future heart disease include:
High blood pressure during pregnancy.
Preeclampsia.
Gestational diabetes.
Premature birth.
Stillbirth.
The guidelines stress that the end of pregnancy does not mean the end of the risks associated with these complications. Instead, doctors should utilize the health information revealed by pregnancy to develop a long-term monitoring and prevention plan.
Postpartum Heart Health Monitoring is a Key Prevention Opportunity
The recommendations emphasize the importance of healthcare during the postpartum period as a fundamental opportunity to detect and manage cardiovascular risk factors early.
American Heart Association data indicates that only about 60% of women in the United States who experienced complications related to high blood pressure during pregnancy undergo blood pressure monitoring in the six months following childbirth.
This reflects a gap in health monitoring after pregnancy, even though complications occurring during it can be important indicators of future cardiovascular risks.
The new guidelines call for adopting a more integrated approach to women's care, so that heart health monitoring becomes a continuous part of medical care across various life stages, rather than just a response to a health issue that appears at a specific time.
